4//SEC Filing
TRENARY C RUSSELL III 4
Accession 0001256928-09-000009
CIK 0001168335other
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 7:46 PM ET
Size
41.6 KB
Accession
0001256928-09-000009
Insider Transaction Report
Form 4
Transactions
- Tax Payment
Common Stock
2009-02-25$22.01/sh−860$18,929→ 1,019 total - Disposition to Issuer
Common Stock
2009-02-26$22.00/sh−1,019$22,418→ 0 total - Disposition to Issuer
Common Stock
2009-02-26$22.00/sh−1.516$33→ 0 total(indirect: By Trust) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2009-02-26−50,000→ 0 totalExercise: $33.72From: 2008-05-20Exp: 2014-05-20→ Common Stock (50,000 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2009-02-26−50,000→ 0 totalExercise: $38.20From: 2009-05-26Exp: 2019-05-26→ Common Stock (50,000 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2009-02-26−39,000→ 0 totalExercise: $45.26From: 2010-05-24Exp: 2016-05-24→ Common Stock (39,000 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2009-02-26−55,900→ 0 totalExercise: $42.55From: 2011-05-21Exp: 2017-05-21→ Common Stock (55,900 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2009-02-26−50,000→ 0 totalExercise: $22.94From: 2012-05-29Exp: 2018-05-29→ Common Stock (50,000 underlying) - Disposition from Tender
Common Stock
2009-02-25$22.00/sh−7,699.679$169,393→ 759.61 total - Disposition to Issuer
Common Stock
2009-02-26$22.00/sh−759.61$16,711→ 0 total - Award
Common Stock
2009-02-25+496→ 496 total - Tax Payment
Common Stock
2009-02-25$22.01/sh−227$4,996→ 269 total - Disposition to Issuer
Common Stock
2009-02-26$22.00/sh−269$5,918→ 0 total - Award
Common Stock
2009-02-25+2,540→ 2,540 total - Tax Payment
Common Stock
2009-02-25$22.01/sh−1,163$25,598→ 1,377 total - Disposition to Issuer
Common Stock
2009-02-26$22.00/sh−1,377$30,294→ 0 total - Award
Common Stock
2009-02-25+3,451→ 3,451 total - Tax Payment
Common Stock
2009-02-25$22.01/sh−1,579$34,754→ 1,872 total - Disposition to Issuer
Common Stock
2009-02-26$22.00/sh−1,872$41,184→ 0 total - Award
Common Stock
2009-02-25+1,879→ 1,879 total
Footnotes (11)
- [F1]These shares were tendered to Rainforest Acquisition Inc. ("Purchaser") pursuant to Purchaser?s offer to purchase all of the outstanding shares of Advanced Medical Optics, Inc. (the "Issuer") at a cash purchase price of $22.00 per share, without interest, and subject to any required withholding taxes, subject to the terms described in the Offer to Purchase, filed with the SEC on January 27, 2009, as amended (the "Tender Offer"). Such shares were purchased by Purchaser pursuant to the Tender Offer on February 25, 2009.
- [F10]This previously reported exempt stock option, which became 100% vested on December 31, 2008 in connection with the reporting person's termination of employment, will be exchanged for a fully vested stock option issued by Abbott Laboratories to purchase 22,935 shares of Abbott Laboratories common stock at an exercise price of $103.71 per share, determined pursuant to a formula set forth in the Merger Agreement.
- [F11]This previously reported exempt stock option, which became 100% vested on December 31, 2008 in connection with the reporting person's termination of employment, will be exchanged for a fully vested stock option issued by Abbott Laboratories to purchase 20,514 shares of Abbott Laboratories common stock at an exercise price of $55.92 per share, determined pursuant to a formula set forth in the Merger Agreement.
- [F2]Includes an aggregate of 759.6096 shares of common stock acquired through the issuer's Employee Stock Purchase Plan through October 31, 2008.
- [F3]These shares were canceled pursuant to the Agreement and Plan of Merger, dated January 11, 2009, by and among Abbott Laboratories, Purchaser and the Issuer (the "Merger Agreement"), in exchange for the right to receive cash payment of $22.00 per share in cash (without interest and subject to any required withholding taxes) at the effective time of the merger.
- [F4]Exempt restricted shares of common stock forfeited in connection with termination of employment were reinstated pursuant to change in control agreement.
- [F5]Shares withheld in satisfaction of tax obligations attributable to the lapse of restrictions on stock award or in satisfaction of tax withholding attributable to vesting and settlement of restricted stock units.
- [F6]The exempt restricted stock units (previously reported on Table II) that had been forfeited in connection with the reporting person's termination of employment were reinstated pursuant to a change in control agreement, vested in full and were settled for shares of Issuer Common Stock in accordance with the terms of the applicable equity plan. At the effective time of the merger, such shares were cancelled pursuant to the Merger Agreement in exchange for the right to receive cash payment of $22.00 per share in cash (without interest and subject to any required withholding taxes).
- [F7]This previously reported exempt stock option, which had vested ratably over four years from the date of grant, will be exchanged for a fully vested stock option issued by Abbott Laboratories to purchase 20,514 shares of Abbott Laboratories common stock at an exercise price of $82.19 per share, determined pursuant to a formula set forth in the Merger Agreement.
- [F8]This previously reported exempt stock option, which became 100% vested on December 31, 2008 in connection with the reporting person's termination of employment, will be exchanged for a fully vested stock option issued by Abbott Laboratories to purchase 20,514 shares of Abbott Laboratories common stock at an exercise price of $93.11 per share, determined pursuant to a formula set forth in the Merger Agreement.
- [F9]This previously reported exempt stock option, which became 100% vested on December 31, 2008 in connection with the reporting person's termination of employment, will be exchanged for a fully vested stock option issued by Abbott Laboratories to purchase 16,001 shares of Abbott Laboratories common stock at an exercise price of $110.32 per share, determined pursuant to a formula set forth in the Merger Agreement.
Documents
Issuer
ABBOTT MEDICAL OPTICS INC
CIK 0001168335
Entity typeother
Related Parties
1- filerCIK 0001227307
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 7:46 PM ET
- Size
- 41.6 KB